Recent research has shown that certain forms of E. coli bacteria tend to colonize hypoxic areas of the body, including tumors, suggesting they might be playing a role in cancer therapeutics.

Tapping into a cancer patient's "yin and yang" immunity could help boost their chances of survival, according to two new ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, Ph.D., Chair of Cleveland Clinic's Global Center for ...

Researchers at the Spanish National Cancer Research Center (CNIO) propose a new treatment for brain metastases that respond ...

An oncologist tells PEOPLE about the innovative cancer treatment that extended the former president’s life as he celebrates ...

Immunotherapy biologics represent a transformative approach in treating cancer and infections by using biological molecules to strengthen the immune system’s response. Biologics such as monoclonal ...

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

The global allergy immunotherapy market is projected to reach USD 1.74 billion in 2023, with robust growth expected over the ...

the way that immunotherapy and chemotherapy target cancer is where they diverge most - Chemotherapy: Chemotherapy targets cancer cells that proliferate quickly. Because they obstruct cell division ...

Or from your operation if you had one. The results of the tests show whether a targeted cancer drug or immunotherapy is suitable for you. If your cancer has a particular protein on its surface, your ...

SAN DIEGO — For years, Merck’s drug Keytruda has dominated cancer immunotherapy, racking up dozens of approvals, extending the lives of patients, and bringing in billions of dollars to the ...

A Cleveland Clinic-led research collaboration between Timothy Chan, MD, PhD, Chair of Cleveland Clinic’s Global Center for ...